Needham & Company Downgrades Genomic Health Inc. (GHDX) to Hold Following Acquisition
Tweet Send to a Friend
Needham & Company analyst Stephen Unger downgraded Genomic Health Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
